Skip to main content

VAN ECK ASSOCIATES CORP

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 869178 NEW YORK, NY

Position in ALNY

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$17,912,308
-$1,143,875 QoQ
Shares Held
54,137
+13.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

VAN ECK ASSOCIATES CORP holds $332,748,136 across 30 Biotechnology names. ALNY ranks #5 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ALNY
Alnylam Pharmaceuticals, Inc.
This page
54,137 $17,912,308

All Filings in ALNY

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,912,308 54,137
2025-12-31 $19,056,183 47,922
2025-09-30 $18,756,648 41,133
2025-06-30 $17,791,469 54,560
2025-03-31 $17,320,162 64,144
2024-12-31 $15,958,252 67,818
2024-09-30 $15,786,446 57,399
2024-06-30 $14,807,934 60,938
2024-03-31 $8,656,591 57,923
2023-12-31 $11,720,608 61,233
2023-09-30 $12,589,330 71,086
2023-06-30 $14,809,241 77,968
2023-03-31 $16,282,209 81,281
2022-12-31 $21,954,106 92,380
2022-09-30 $13,990,382 69,896
2022-06-30 $15,962,115 109,442
2022-03-31 $16,329,979 100,006
2021-12-31 $16,722,962 98,614
2021-09-30 $17,502,875 92,701
2021-06-30 $20,447,841 120,622
2021-03-31 $14,154,862 100,254
2020-12-31 $13,676,613 105,229
2020-09-30 $12,585,518 86,439
2020-06-30 $16,439,913 110,998
2020-03-31 $9,470,385 87,004